Skip to content
Biodatica
Start free

Investigator

Miles A Miller

MASSACHUSETTS GENERAL HOSPITAL · funded by NCI, NIGMS

Companies
1

Resolved onto their grants.

Grants
6

Federal awards on file.

Non-dilutive funding
$3.6M

Summed across those awards.

First award
Sep 20, 2022

Latest Jun 4, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Spatial control of synthetic immunogenic cytotoxicity for the treatment of locally advanced lung cancer

    $682k

    Jun 4, 2026NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11428611 (opens the source filing in a new tab)

  2. R01

    Imaging radiation-enhanced drug delivery for safer and more effective chemoradiotherapy

    $663k

    Mar 11, 2025NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11127053 (opens the source filing in a new tab)

  3. R01

    Expanding the therapeutic window of chemoradiation through radiation-responsive nanoparticle drug depots

    $644k

    Mar 11, 2025NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11083240 (opens the source filing in a new tab)

  4. R01

    Imaging radiation-enhanced drug delivery for safer and more effective chemoradiotherapy

    $663k

    Mar 11, 2025NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11294368 (opens the source filing in a new tab)

  5. R01

    Expanding the therapeutic window of chemoradiation through radiation-responsive nanoparticle drug depots

    $639k

    Mar 11, 2025NCIMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11301009 (opens the source filing in a new tab)

  6. R01

    Molecular profiling of global tissue dynamics at sub cellular resolution

    $333k

    Sep 20, 2022NIGMSMASSACHUSETTS GENERAL HOSPITALNIH RePORTER · 11135485 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources